4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-23-001803
Interim President & CEO sold 6,766 shares at $15.00 ($101,490)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gould Robert J Interim President & CEO | 2023-01-13 | Sale | −6,766 | $15.00 | $101,490 | 499,864 | D |
| Open-market sales · 6,766 sh · avg $15.00 · $101,490 | |||||||
Loading xslF345X03/doc4.xml…